[go: up one dir, main page]

FR2963237B1 - Nouvelle composition pharmaceutique utile pour prevenir ou traiter l'hypotension arterielle peroperatoire chez l'etre humain - Google Patents

Nouvelle composition pharmaceutique utile pour prevenir ou traiter l'hypotension arterielle peroperatoire chez l'etre humain

Info

Publication number
FR2963237B1
FR2963237B1 FR1056209A FR1056209A FR2963237B1 FR 2963237 B1 FR2963237 B1 FR 2963237B1 FR 1056209 A FR1056209 A FR 1056209A FR 1056209 A FR1056209 A FR 1056209A FR 2963237 B1 FR2963237 B1 FR 2963237B1
Authority
FR
France
Prior art keywords
peroperative
treating
preventing
pharmaceutical composition
human beings
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR1056209A
Other languages
English (en)
Other versions
FR2963237A1 (fr
Inventor
Jean-Michel Julia
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoire Aguettant SAS
Original Assignee
Laboratoire Aguettant SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoire Aguettant SAS filed Critical Laboratoire Aguettant SAS
Priority to FR1056209A priority Critical patent/FR2963237B1/fr
Priority to EP11752302.7A priority patent/EP2598130A1/fr
Priority to US13/812,206 priority patent/US20130123298A1/en
Priority to PCT/FR2011/051803 priority patent/WO2012022896A1/fr
Priority to CA2803349A priority patent/CA2803349A1/fr
Priority to RU2013108390/15A priority patent/RU2013108390A/ru
Publication of FR2963237A1 publication Critical patent/FR2963237A1/fr
Application granted granted Critical
Publication of FR2963237B1 publication Critical patent/FR2963237B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4748—Quinolines; Isoquinolines forming part of bridged ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR1056209A 2010-07-28 2010-07-28 Nouvelle composition pharmaceutique utile pour prevenir ou traiter l'hypotension arterielle peroperatoire chez l'etre humain Expired - Fee Related FR2963237B1 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
FR1056209A FR2963237B1 (fr) 2010-07-28 2010-07-28 Nouvelle composition pharmaceutique utile pour prevenir ou traiter l'hypotension arterielle peroperatoire chez l'etre humain
EP11752302.7A EP2598130A1 (fr) 2010-07-28 2011-07-27 Composition pharmaceutique pour la prevention de l'hypotension arterielle peroperatoire chez l' etre humain
US13/812,206 US20130123298A1 (en) 2010-07-28 2011-07-27 Pharmaceutical composition for the prevention of perioperative arterial hypotension in humans
PCT/FR2011/051803 WO2012022896A1 (fr) 2010-07-28 2011-07-27 Composition pharmaceutique pour la prevention de l'hypotension arterielle peroperatoire chez l' etre humain
CA2803349A CA2803349A1 (fr) 2010-07-28 2011-07-27 Pharmaceutical composition for the prevention of perioperative arterial hypotension in humans
RU2013108390/15A RU2013108390A (ru) 2010-07-28 2011-07-27 Фармацевтическая композиция для предотвращения периоперационной артериальной гипотензии у человека

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1056209A FR2963237B1 (fr) 2010-07-28 2010-07-28 Nouvelle composition pharmaceutique utile pour prevenir ou traiter l'hypotension arterielle peroperatoire chez l'etre humain

Publications (2)

Publication Number Publication Date
FR2963237A1 FR2963237A1 (fr) 2012-02-03
FR2963237B1 true FR2963237B1 (fr) 2013-05-17

Family

ID=42751910

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1056209A Expired - Fee Related FR2963237B1 (fr) 2010-07-28 2010-07-28 Nouvelle composition pharmaceutique utile pour prevenir ou traiter l'hypotension arterielle peroperatoire chez l'etre humain

Country Status (6)

Country Link
US (1) US20130123298A1 (fr)
EP (1) EP2598130A1 (fr)
CA (1) CA2803349A1 (fr)
FR (1) FR2963237B1 (fr)
RU (1) RU2013108390A (fr)
WO (1) WO2012022896A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9381166B2 (en) * 2007-10-02 2016-07-05 Rigshospitalet Systemic pro-hemostatic effect of sympathicomimetics with agonistic effects on alfa-adrenergic and/or beta-adrenergic receptors of the sympathetic nervous system, related to improved clot strength
UY35988A (es) 2014-02-27 2015-09-30 Sint Sa Proceso para la producción de una solución inyectable de noradrenalina de baja concentración
US20250177328A1 (en) 2017-01-30 2025-06-05 Nevakar Injectables Inc. Norepinephrine compositions and methods therefor
WO2018140894A1 (fr) 2017-01-30 2018-08-02 Nevakar, Inc Compositions de norépinéphrine et procédés associés
US11213258B2 (en) * 2017-08-09 2022-01-04 University of Pittsburgh—of the Commonwealth System of Higher Education Variable index for determining patient status
AU2020276619A1 (en) 2019-05-16 2021-12-16 Nexus Pharmaceuticals, Inc. Compositions comprising ephedrine or an ephedrine salt and methods of making and using same
EP4114336A1 (fr) 2020-03-06 2023-01-11 Baxter International Inc. Système de récipient scellé conditionné de stockage stable de formulation pharmaceutique sensible à l'oxygène

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040136915A1 (en) * 1997-10-01 2004-07-15 Dugger Harry A. Buccal, polar and non-polar spray containing atropine

Also Published As

Publication number Publication date
WO2012022896A1 (fr) 2012-02-23
EP2598130A1 (fr) 2013-06-05
US20130123298A1 (en) 2013-05-16
RU2013108390A (ru) 2014-09-10
CA2803349A1 (fr) 2012-02-23
FR2963237A1 (fr) 2012-02-03

Similar Documents

Publication Publication Date Title
EP2389187A4 (fr) Acide sorbique et benzoïque et dérivés de celui-ci pour améliorer l'activité d'un produit neuropharmaceutique
EP2301560A4 (fr) Agent pharmaceutique pour favoriser la régénération fonctionnelle d'un tissu lésé
FR2963237B1 (fr) Nouvelle composition pharmaceutique utile pour prevenir ou traiter l'hypotension arterielle peroperatoire chez l'etre humain
EP2544642A4 (fr) Produit de bandage médical résistant à l'eau
EP3466408C0 (fr) Composition pharmaceutique liquide destinée au traitement d'une maladie de l'oeil postérieur
EP2718318A4 (fr) Dérivés inédits d'oxyntomoduline et composition pharmaceutique destinée au traitement de l'obésité en contenant
EP2152290A4 (fr) Méthodes pour administrer des anticorps anti-il-5
EP2381773A4 (fr) Compositions pour administration de médicaments
EP2528603A4 (fr) Compositions pharmaceutiques pour le traitement de la douleur et d'autres indications
EP2284165A4 (fr) Sel de phosphonium, photogénérateur d'acide, composition photodurcissable, et produit durci de la composition photodurcissable
CL2013001947A1 (es) Composicion farmaceutica que comprende pioglitazona; uso de pioglitazona para tratar alzheimer; composicion que comprende pioglitazona.
FR2961814B1 (fr) Nouveaux peptides activateurs de la sirtuine 6 et composition cosmetique ou pharmaceutiques les comprenant.
EP2634199A4 (fr) Composition d'acrylate ou de méthacrylate
EP2301525A4 (fr) Préparation topique d'ibuprofène
EP2135858A4 (fr) Composition destinée à traiter des maladies infectieuses
EP2654745A4 (fr) Composition pour le traitement d'états pathologiques de la peau
IL251543A0 (en) Use of a topical gel composition in the manufacture of a medicament for the prevention or treatment of a skin disorder
EP2601951A4 (fr) Composition pharmaceutique destinée au traitement d'une hémorragie provoquée par un trouble de la coagulation et utilisation associée
FR2962650B1 (fr) Composition d'immunoglobulines humaines concentrees
EP2655651A4 (fr) Procédé peu coûteux d'expression et purification de protéines recombinantes dans des plantes
EP2783704A4 (fr) Composition pharmaceutique utile pour empêcher les adhérences ou pour l'hémostase
FR2933271B1 (fr) Compositions topiques pour la conservation du corps humain ou animal
EP2210621A4 (fr) Composition pour le traitement d'une affection articulaire
EP2640408A4 (fr) Compositions kératiniques pour le traitement d'une déficience ou lésion osseuse
EP2296665A4 (fr) Composition pharmaceutique destinée au traitement de l'éjaculation précoce

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 7

PLFP Fee payment

Year of fee payment: 8

PLFP Fee payment

Year of fee payment: 9

PLFP Fee payment

Year of fee payment: 11

PLFP Fee payment

Year of fee payment: 12

PLFP Fee payment

Year of fee payment: 13

PLFP Fee payment

Year of fee payment: 14

ST Notification of lapse

Effective date: 20250305